Robert Paul Myers
CIK: 0002155916
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MIRM
Mirum Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
About Myers Robert Paul
Myers Robert Paul (SEC CIK 0002155916) files insider reports with the SEC as Chief Medical Officer of Mirum Pharmaceuticals, Inc. (MIRM).
Signal8 holds 2 ownership filings by Myers Robert Paul (1 Form 3, 1 Form 4), filed between Sep 22, 2026 and Oct 14, 2026. Those filings report 2 transactions, the latest on Oct 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Myers Robert Paul's filings is in FOSTER CITY, CA.
Recent filings by Myers Robert Paul
- Oct 9, 2026: Grants or awards of MIRM derivative securities (2 lines, Form 4, code A).
Other insiders filing for Mirum Pharmaceuticals, Inc. (MIRM)
- Howe Jolanda, SVP, GLOBAL CONTROLLER
- Peetz Christopher, CHIEF EXECUTIVE OFFICER
- BJERKHOLT ERIC, CHIEF FINANCIAL OFFICER
- Walbert Timothy P, Director
- Cardon Lon, Director
- Ramasastry Saira, Director